Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why TPL and Alliasence need to be removed from control of MMP licensing

"IMO, the concept of escaping DL/TPL/Alliacense (and what I consider no longer anywhere near as big an issue as it once was) , no matter how desireable it may be, is so riddled with difficulties, pitfalls and flaws.....

There is NO practical way to get rid of DL/TPL without destroying the value of MMP and until now = seven days after the verdict there is NO reasonable reason to pursue this.

... all this talk on Agora may be scaring off would-be investors. How does that help those already invested?"

It's like biting the hand that feeds you, isn't it?

Share
New Message
Please login to post a reply